|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows From Operating Activities: | |||||
| Net Loss | |||||
| Adjustments To Reconcile Net Loss To Net Cash (Used In) Provided By Operating Activities: | |||||
| Depreciation and Amortization | |||||
| Stock-based Compensation | |||||
| Write-off of Inventory | |||||
| Change in Inventory Reserves | |||||
| Non-cash Lease Expense from Right of Use Assets | |||||
| Amortization of Debt Financing Costs and Accretion of Debt Discount and Premium | |||||
| Loss on Disposal of Assets | |||||
| Realized Gain on Sale of Investments | |||||
| Gain on Early Termination of Lease Liability | |||||
| Provision for Credit Losses | |||||
| Changes in Assets and Liabilities: | |||||
| Accounts Receivable | |||||
| Inventory | |||||
| Prepaid and Other Assets | |||||
| Accounts Payable | |||||
| Lease Liabilities | |||||
| Accrued and Other Liabilities | |||||
| Deferred License Revenue | |||||
| Changes in Operating Assets and Liabilities | |||||
| Net Cash (Used In) Provided by Operating Activities | |||||
| Cash Flows From Investing Activities: | |||||
| Purchases of Investments Available-for-Sale | |||||
| Proceeds from Sales of Investments Available-for-Sale | |||||
| Purchase of Equipment | |||||
| Purchases of Equipment | |||||
| Cash Paid in Connection with Evoqua Asset Acquisition | |||||
| Net Cash Used In Investing Activities | |||||
| Cash Flows From Financing Activities: | |||||
| Payments on Debt | |||||
| Payments on Insurance Financing Note Payable | |||||
| Payments on Finance Lease Liabilities | |||||
| Proceeds from Issuance of Common Stock | |||||
| Total proceeds from Issuance of Common Stock | |||||
| Offering Costs from Issuance of Common Stock | |||||
| Total offering Costs from Issuance of Common Stock | |||||
| Proceeds from Issuance of Preferred Stock | |||||
| Offering Costs from Issuance of Preferred Stock | |||||
| Deferred Consideration Paid in Connection with Evoqua Asset Acquisition | |||||
| Net Cash Provided By Financing Activities | |||||
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | |||||
| Net (Decrease) Increase in Cash and Cash Equivalents | |||||
| Cash and Cash Equivalents at Beginning of Year | |||||
| Cash and Cash Equivalents at End of Year | |||||
| Supplemental Disclosure of Cash Flow Information: | |||||
| Cash Paid for Interest | |||||
| Supplemental Disclosure of Noncash Investing and Financing Activities: | |||||
| Change in Unrealized (Loss) Gain on Marketable Securities Available-for-Sale | |||||
| Issuance of Warrant in Connection with the Third Amendment as Debt Issuance Costs | |||||
| Right of Use Assets - Operating Obtained in Exchange for Lease Liabilities - Operating | |||||
| De-recognition of Lease Liability - Finance and Right of Use Asset - Finance Upon Early Termination | |||||
| Change in Unrealized Gain on Investments Available-for-Sale | |||||
| Deferred Consideration from Evoqua Asset Acquisition | |||||
| Increase in Prepaid Assets from Insurance Financing Note Payable | |||||
| Fair Value of Warrants issued related to Debt Financing | |||||
Loading...